Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04365686
Other study ID # R83
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 1, 2019
Est. completion date April 20, 2020

Study information

Verified date April 2020
Source Fayoum University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the effect of ketofol, a combination of propofol and ketamine, on hemodynamics and airway response during induction of general anesthesia has been studied before. Its effect on the smoothness of extubation has not been studied before. In the present study; we aimed to assess the effect of ketofol on the smoothness of extubation as regards, airway response, sedation score during suction and extubation and hemodynamic changes comparing it with propofol for induction of general anesthesia.


Description:

After securing intravenous access by a 20g catheter, intravenous premedication (midazolam 2 mg and 4mg ondansetron) was administered to all patients. Standard ASA(american society of anesthesiologists) monitoring (5-lead ECG, noninvasive blood pressure (NIBP), and pulse oximetry) was applied to all the patients for the recording of heart rate (HR), NIBP and oxygen saturation by a multiparameter monitor. Induction of general anesthesia was achieved as follows: in Group K (Ketofol group), fifty three female patients received propofol (1mg/kg) plus ketamine (0.5mg/kg) at the induction of general anesthesia while in Group P (Propofol group), fifty three female patients received propofol (2mg/kg) only at the induction of general anesthesia.

Patients in both groups received fentanyl 2 ug\kg and atracurium 0.5 mg\kg. After tracheal intubation, general anesthesia maintained by isoflurane 1.5 volume % in 2 L\min oxygen-air mixture 50:50 and atracurium 0.1 mg\kg every 30 minutes, if needed. At the end of the surgery, inhalational anesthesia was stopped and reversal of the patients was done by injection of neostigmine 0.05mg\ kg and atropine 0.01mg\kg.

Hemodynamics (HR and mean arterial pressure ''MAP'') was assessed at 5 minutes interval from the time of reversal of muscle relaxant up to 30 minutes after extubation.

The level of sedation during suction and extubation was assessed using observer assessment sedation score and the airway response under direct laryngoscopy to suction was noted by five-point scale. After 5 minute interval, the level of sedation and smoothness of extubation was noted by four-point scale.


Recruitment information / eligibility

Status Completed
Enrollment 106
Est. completion date April 20, 2020
Est. primary completion date April 12, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists Physical status ''ASA PS'' class I and II scheduled for laparoscopic drilling for polycystic ovary under general anesthesia.

Exclusion Criteria:

- from cardiac, hepatic, renal diseases, history of epilepsy

- Patient refusal.

- known drug allergy.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ketofol as induction agent
Patients who received propofol (1mg/kg) plus ketamine (0.5mg/kg) at the induction of general anesthesia
Propofol as induction agent
Patients who received propofol (2mg/kg) only at the induction of general anesthesia.

Locations

Country Name City State
Egypt Fayoum University hospital Fayoum Madinat Al Fayyum, Faiyum Governorate, Egypt

Sponsors (1)

Lead Sponsor Collaborator
Fayoum University Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary smoothness of extubation Smoothness of extubation Grade Description
No coughing on endotracheal tube
Coughing on the tube
Vomiting
Laryngospasm
5 minutes after extubation
Secondary airway response to laryngoscopy and suction Grading of air way reflexes Grade Description
Excellent(breathing well, no response to laryngoscopy& suctioning)
Good(breathing well, minimal grimacing response to laryngoscope& suctioning)
Satisfactory (breathing well coughing attempt to laryngoscopy& suctioning)
Poor (breathing well, coughing on tube laryngoscopy)
Very poor (breathing well, coughing on tube laryngoscopy)
5 minutes after extubation
Secondary sedation score Observer assessment sedation score Observation Score Responds readily to name spoken in normal tone 5 Lethargic response to name spoken in normal tone 4 Responds only after name is called loudly and\or repeatedly 3 Responds only after mild podding or shaking 2 Dose not responds to mild podding or shaking 1 5 minutes after extubation
Secondary Age In years 6 hours before intervention
Secondary weight In kilograms 6 hours before intervention
Secondary Height In meters 6 hours before intervention
Secondary BMI In kilogram per square meter 6 hours before intervention
Secondary mean arterial pressure (MAP) hemodynamic parameter 5 minutes before extubation
Secondary mean arterial pressure (MAP) hemodynamic parameter 1 minute after extubation
Secondary mean arterial pressure (MAP) hemodynamic parameter 5 minutes after extubation
Secondary mean arterial pressure (MAP) hemodynamic parameter 10 minutes after extubation
Secondary mean arterial pressure (MAP) hemodynamic parameter 15 minutes after extubation
Secondary mean arterial pressure (MAP) hemodynamic parameter 20 minutes after extubation
Secondary heart rate (HR) hemodynamic parameter 5 minutes before extubation
Secondary heart rate (HR) hemodynamic parameter 1 minute after extubation
Secondary heart rate (HR) hemodynamic parameter 5 minutes after extubation
Secondary heart rate (HR) hemodynamic parameter 10 minutes after extubation
Secondary heart rate (HR) hemodynamic parameter 15 minutes after extubation
Secondary heart rate (HR) hemodynamic parameter 20 minutes after extubation
See also
  Status Clinical Trial Phase
Completed NCT04617652 - Smooth Extubation With Magnesium Sulphate for General Anesthesia With Endotracheal Intubation Phase 4